IJ Pharmaceutical Research
Scopus by Title (Ref)
1. TRPV1 antagonist AMG9810 suppresses focal epileptiform discharges and seizures by decreasing extracellular glutamate concentrations in mice
- Moriyama H. , et al.
2. TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates
- Socała K. , et al.
3. CANNABINOID TREATMENTS IN EPILEPSY AND SEIZURE DISORDERS
- Devinsky O. , et al.
4. The CB1 cannabinoid receptors involvement in anti-epileptic effect of safranal on penicillin-induced epileptiform activity in rats
- Tamaddonfard S. , et al.
5. The Role of the Possible Receptors and Intracellular Pathways in Protective Effect of Exogenous Anandamide in Kindling Model of Epilepsy
- Khaksar S. , et al.
6. Neural stem cells and cannabinoids in the spotlight as potential therapy for epilepsy
- Lourenço D.M. , et al.
7. Trehalose neuroprotective effects on the substantia nigra dopaminergic cells by activating autophagy and non-canonical Nrf2 pathways
- Darabi S. , et al.
8. Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model
- Nazıroğlu M. , et al.
9. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection
- Rosenberg E.C. , et al.
10. The role of BK channels in antiseizure action of the CB1 receptor agonist ACEA in maximal electroshock and pentylenetetrazole models of seizure in mice
- Asaadi S. , et al.
11. Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy
- Carletti F. , et al.
12. The pharmacological basis of cannabis therapy for epilepsy
- Reddy D.S. , et al.